Panel of HuCAL Anti-Drug Antibodies to be launched by AbD Serotec News-Medical.net Starting with the recent launch of fully human, recombinant antibodies binding Rituximab (Rituxan ® ) and Trastuzumab (Herceptin ® ), AbD Serotec plans to expand this product category with antibodies against Alemtuzumab (Campath ® ), Bevacizumab ... MorphoSys' Unit To Intorduce Series Of Novel Anti-drug Antibodies - Quick Facts |
